Category Archives: Regulations

TMF Reference Model Gains Momentum

Posted on May 9, 2012 by

The Trial Master File Reference Model (TMF RM), a supported initiative through the Document and Records Management SIAC of the Drug Information Association (DIA) is a standard reference for the contents of a Trial Master File. First published in 2010, … Continue reading →

Posted in Regulations, TMF | Leave a comment

GCP Records Management – How Are We Doing in Canada?

Posted on April 20, 2012 by

Health Canada has recently released a publication summarising the results of GCP inspections carried out between April 2004 and March 2011. It makes for interesting reading compared to a similar document released by the MHRA three years ago. At 24.5% … Continue reading →

Posted in Compliance, e-records, Regulations, TMF | Leave a comment

Is Facebook a Validated System?

Posted on February 27, 2012 by

Well, of course the answer to the question posed in the title is a clear “No”…. at least as far as the pharmaceutical and biopharmaceutical industry understands and interprets validation. So why the question? My eye was drawn to an … Continue reading →

Posted in e-records, Regulations | Tagged , | Leave a comment

Ensure Your Informed Consent Forms Comply With New Requirements

Posted on February 10, 2012 by

For those sponsors conducting clinical trials that need to comply with FDA regulations, remember that from 7th March 2012 your informed consent documentation must comply with the new 21 CFR § 50.25(c) requirement. This requires the informed consent form to … Continue reading →

Posted in Compliance, Regulations | Leave a comment

GMP Directive (2003/94/EC) to cover active substances?

Posted on January 24, 2012 by

The European Commission are proposing to extend the scope of Directive 2003/94/EC to cover active substances, including the manufacture of active substances. The intent is to bring cohesion of requirements for active substances and medicinal products. However, since all of … Continue reading →

Posted in Compliance, GMP, Regulations | Leave a comment

Is it OK to “manipulate” PDFs to improve records management?

Posted on January 23, 2012 by

This is a question that I hear posed fairly frequently, I guess as a result of organisations managing electronic records rather than – or in addition to – traditional paper records. A typical scenario is an electronic document received into the … Continue reading →

Posted in Compliance, e-records, Litigation, Records management practice, Regulations | 1 Comment

Certification by a qualified person and batch release – Consultation

Posted on January 5, 2012 by

A concept paper on revising Annex 16 of the guide to good manufacturing practice: certification by a QP and batch release is currently open for consultation until 31/01/2012 using the following link to the EMA website: http://bit.ly/yTocBW The concept paper … Continue reading →

Posted in Regulations | Tagged , , , , | Leave a comment

MHRA Opens Public Consultation on Review of UK Medicines Legislation

Posted on November 24, 2011 by

On 25th October, the MHRA opened a consultation period of 12 weeks for their review and consolidation of UK legislation pertinent to manufacture and use of medicines. Many requirements relating to the creation, management and retention of medical records are … Continue reading →

Posted in Regulations, TMF | Leave a comment

Documentation Risk Adaptations in Clinical Trials

Posted on October 30, 2011 by

A paper has recently been published under the joint auspices of the UK Department of Health (DH), the Medicines and Healthcare products Regulatory Agency (MHRA) and Medical Research Council (MRC) describing risk-adapted approaches to the management of clinical trials of … Continue reading →

Posted in Compliance, Records management practice, Regulations, TMF | Leave a comment

Financial Disclosure to FDA – New Draft Guidance Available

Posted on May 25, 2011 by

Yesterday, 24 May 2011, the Food & Drug Administration (FDA) released for public review and comment a draft revision of the guidance for financial disclosure by clinical investigators. This will replace the last guidance issued back in 2001. The revised … Continue reading →

Posted in Regulations, TMF | Leave a comment